2022, Number 1
Considerations on the treatment of Wilms’ tumor
Language: Spanish
References: 26
Page: 1-8
PDF size: 162.71 Kb.
ABSTRACT
Introduction: Wilms’ tumor is the most common renal neoplasm in childhood, which makes it necessary to be updated in terms of its treatment.Objective: to describe the treatment of Wilms’ tumor.
Method: a literature review was carried out in the Web of Science, Scopus, PubMed, ClinicalKey and SciELO databases. The search strategy used was a combination of terms, using the name of the disease and treatments. Twenty-six references were chosen.
Development: Wilms’ tumor represents a malignant tumor with a high cure rate; which is possible thanks to the development of surgical techniques, application of chemotherapy and recognition of the role of radiotherapy. These techniques used rationally have a great impact on the survival rate to this neoplasm. A fundamental pillar in the management of this entity is nephrectomy. There are two positions according to the moment of treatment with chemotherapy; before and after the surgical procedure. Radiotherapy is another modality in the treatment of nephroblastoma; it is used in advanced stages or in conditions where there are associated risk factors.
Conclusions: the treatment of Wilms’ tumor depends on the histological classification and staging. Its treatment is multidisciplinary and includes the combination of surgery, chemotherapy and radiotherapy. The application of the existing therapeutic protocols, as long as the parameters they establish are maintained, will have successful results in spite of the different sequences in which the therapeutic modalities are used.
REFERENCES
Mirabal Fariñas A, Yalcouye H, Pantoja Blanco M, Cobas Landeau C, Romero García LI. Características clinicoterapéuticas de niños y adolescentes con neoplasias renales. MEDISAN [Internet]. 2015 [citado 10/03/2020]; 19(7): 821-30. Disponible en: http://www.medisan.sld.cu/index.php/san/article/view/378/html_101
Quero-Hernández A, Hernández Arriola J, Reyes Gómez U, Álvarez Solís RM, Vargas M, Tenorio Rodríguez H. Tumor de Wilms. Características clínicas y resultados del tratamiento. Pediat Mex [Internet]. 2011 [citado 10/03/2020]; 13(3): 109-113. Disponible en: http://www.medigraphic.com/pdfs/conapeme/pm-2011/pm113e.pdf
Seminara C, Planells MC, Pogonza RE, Morales M, Castro C, Sferco A, et al. Tumor de Wilms: experiencia de 15 años en un Hospital de niños, Córdoba, Argentina. Arch Argent Pediatr [Internet]. 2019 [citado 10/03/2020]; 117(4): 263-270. Disponible en: https://pmlegacy.ncbi.nlm.nih.gov/pubmed/?term=Tumor+de+wilms%3A+experiencia+de+15+años+en+un+hospital+de+niños
Herrera-Toro NH, Peña-Aguirre L, Arango-Rave ME. Tumor de Wilms: experiencia de 12 años en dos hospitales de alto nivel en Medellín, Colombia. IATREIA [Internet]. 2019 [citado 19/03/2020]; 32(2): 82-91. Disponible en: http://www.scielo.org.co/scielo.php?pid=S0121-07932019000200082&script=sci_abstract&tlng=es
Cordero MG, Aldrink JH, O’Brien SH, Yin H, Arnold MA, Ranalli MA. Renal tumors in children younger than 12 months of age: a 65-year single institution review. J Pediatr Hematol Oncol [Internet]. 2017 [citado 19/03/2020]; 39(2): 103-7. Disponible en: https://pmlegacy.ncbi.nlm.nih.gov/pubmed/?term=Renal+tumors+in+children+younger+than+12+minths+of+age%3A+a+65-year+single+institution+review
Xiao‑Hui T, De‑Ying Z, Xing L, Tao L, Da‑Wei H, Xu‑Liang L, et al. Retrospective analysis to determine outcomes of patients with bilateral Wilms tumor undergoing nephron sparing surgery: 15-year tertiary single-institution experience. Pediatr Surg Int [Internet]. 2018 [citado 19/03/2020]; 34(4): 427-33. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29368077
Guerrero E, Alvarado R, Urdiales A, Orbe MJ, Navarrete O, Manterola C. Tumor de Wilms: estudio de centro único de los andes ecuatorianos. Serie de casos con seguimiento. Int J Morphol [Internet]. 2020 [citado 05/04/2020]; 38(1): 208-214. Disponible en: https://scielo.conicyt.cl/scielo.php?pid=S0717-95022020000100208&script=sci_arttext
Lecca-Zavaleta JL, Salirrosas Bermudez SV. Dolor abdominal agudo secundario a la rotura de tumor de Wilms: reporte de caso. Urol Colomb [Internet]. 2019 [citado 19/03/2020]; 28(1): 88–91. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0038-1651511?device=mobile&innerWidth=360&offsetWidth=360
Jia-Yi P, Hsing-Ju W, Su-Boon Y. Atypical presentation of Wilmstumor, an 11-year-old girl with abdominal pain and anemia: a case report. Int J Clin Exp Med [Internet]. 2019 [citado 19/03/2020]; 12(7): 9463-9467. Disponible en: https://1library.net/document/qvl5on0y-case-report-atypical-presentation-wilms-abdominal-anemia-report.html
Mahamdallie S, Yost S, Poyastro-Pearson E, Holt E, Zachariou A, Seal S, et al. Identification of new Wilms tumour predisposition genes: an exome sequencing study. Lancet Child Adolesc Health [Internet]. 2019 [citado 27/03/2020]; 3: 322–31. Disponible en: https://www.sciencedirect.com/science/article/pii/S2352464219300185
Dix DB, Seibel N, Chi YY, Khanna G, Gratias E, Anderson J, et al. Treatment of stage IV favorable histology Wilms tumor with lung metastases: a report from the children’s oncology group AREN0533 Study. J Clin Oncol [Internet]. 2018 [citado 05/04/2020]; 36(16): 1564-70. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075846/
Pritchard Jones K, Bergeron C, Camargo B, Heuvel-Eibrink M, Cha T, Godzinki J, et al. Omission of doxorubicin from the treatment of stage II-III intermediate-risk Wilms Tumor (SIOP WT-2001): an open label, non inferiority, randomised controlled trial. Lancet [Internet]. 2015 [citado 19/03/2020]; 386: 1156–64. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26164096/
Stokes C, Stokes W, Kalapurakal J, Paulino A, Cost N, Cost C, et al. Timing of Radiation Therapy in Pediatric Wilms Tumor: A Report From the National Cancer Database. Int J Radiat Oncol Biol Phys [Internet]. 2018 [citado 19/03/2020]; 101(2): 453-61. Disponible en: https://www.ncbi.nlm.nih.gov/m/pubmed/29559286